Torrent Pharmaceuticals Limited has informed the Exchange about Credit Rating
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
India Ratings and Research has affirmed Torrent Pharmaceuticals' existing banking facilities, issuer rating, and Non-Convertible Debentures (NCDs) at IND AA+ with a Stable outlook. Additionally, the agency has assigned a rating of IND A1+ for the company's proposed Commercial Paper. IND AA+ indicates a high degree of safety on long-term obligations, while IND A1+ is the highest short-term rating, reflecting strong capacity to meet short-term commitments. The Stable outlook signals that the rating agency does not expect any near-term change in the company's credit profile.
Positive for shareholders — reaffirms the company's strong financial health and low default risk, while the new A1+ rating enables Torrent to raise short-term funds at competitive rates, supporting working capital and liquidity needs.